IL-33/ST2 signalling promotes tumor growth by regulating polarization of alternatively activated macrophages
Macrophages expressing ST2 can serve as promising therapeutic targets for NSCLC immunotherapy, highlighting the IL-33/ST2 axis as a potential target for future antitumor strategies.
Authors
- Liping Liu (ORCID: https://orcid.org/0000-0002-4373-881X)
- Dong Li (ORCID: https://orcid.org/0000-0002-2508-3282)
- Haiyang Sun
- Yinghong Xie (ORCID: https://orcid.org/0000-0003-3205-003X)
- Ying Wang (ORCID: https://orcid.org/0009-0008-1288-0718)
- Shiying Ren
- Haoge Luo
Institutions
- Jilin University (CN)
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2025-03-27
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2024.0483
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00